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A Test for the Absorption of Thiamine in Man 
SUMMARY: 
(1) A method is described for investigating vitamin B1 absorption in man 
by measuring the urinary radioactivity during the 24 hours following an oral 
dose of radioactive 35S- thiamine which is given along with a parentergl 
injection of non -radioactive thiamine hydrochloride. 
(2) Analysis of small intestinal juice and characterisation of radioactive 
material in the urine indicate that the urine contains radioactive thiamine 
which was unchanged prior to absorption. 
(3) In control subjects, the major period of thiamine absorption occurred 
within the first 2 hours and practically all of the oral dose absorbed was 
excreted during the first 211. hours. 
(4) Eight patients with untreated primary malabsorptive disease (idiopathic 
steatorrhoea) showed a mean urinary excretion of radioactive thiamine sig- 
nificantly less than in the control group. The rate of excretion was markedly 
reduced but the period of maximal excretion occurred at approximately the same 
time as in control subjects. Thirteen patients with treated primary ma3absorp- 
tive disease showed no significant difference from the control group. 
(5) Ten patients who had undergone gastric surgery and two with resection 
of the terminal ileum excreted amounts which did not differ from the control 
group. Normal results were also found in four patients with pernicious 
anaemia. 
A Test for the Absorption of Thiamine in Man 
INTRODUCTION : 
Disease of the small intestine may cause impaired absorption of certain 
water -soluble vitamins. Patients with primary malabsorptive disease (idio- 
pathic steatorrhoea), for example, frequently fail to absorb folic acid 
normally ( Girdwood, 1953; Girdwood & Delamore, 1961; Chanarin, Anderson 
& Mollin, 1958; Gox, Meynell, Cooke & Gaddie, 1958). Although clinical 
evidence of deficiency of other water -soluble vitamins is rarely present, 
investigations using the tryptophan loading test have suggested subclinical 
deficiency of pyridoxine in patients with tropical sprue and primary malab- 
sorptive disease (Kowlessar, Haeffner, Benson & Sleisenger, 1961; Sigler, 
Sheehy, Santini & Rubini, 1962). Baker & Sobotka (1962) have shown that 
patients with primary malabsorptive disease may have subnormal levels of 
serum pyridoxine and Brain & Booth (19610, using tritium- labelled pyridoxine, 
have demonstrated impaired absorption of pyridoxine in some of these patients. 
Girdwood, (1956) using microbiological methods, studied the absorption 
of water soluble vitamins in patients with primary malabsorptive disease, 
but found no evidence of malabsorption of thiamine, riboflavin or pyridoxine 
in 10 patients with impaired absorption of folic acid. Except for this 
investigation, little has been published on the absorption of thiamine in 
patients with intestinal malabsorption. 
The availability of 35S- labelled thiamine has allowed some of the 
limitations of the microbiological methods to be overcome. This paper 
presents a method for the measurement of thiamine absorption using radio- 
active thiamine and compares the results found in control subjects with 
those obtained in various groups of patients with gastro -intestinal disorders. 
MATERIALS AND METHODS 
Materials Used 
All of the thiamine preparations were supplied as the hydrochloride. 
35S- labelled thiamine was obtained from the Radiochemical Centre, Amersham. 
The radioactive material used orally had a specific activity of 177mc /gm and 
was found to be radiochemically pure when tested in the three chromatographic 
systems described below. The solid material was dissolved in distilled water, 
100µc (10 doses) dispensed into each ampoule, freeze dried and stored at -20°C. 
2. 
It was reconstituted by adding 10m1 distilled water. In a few experiments 
radioactive thiamine was used intravenously. This material was supplied 
in aqueous solution pH5; it had a specific activity of 12.Oyic /m1 and 
analysis showed that it was more than 9aX, radiochemically pure. The 
non -radioactive thiamine was supplied in ampoules containing 100mg in 
one ml by Roche Products Ltd, England. 
Method for the Study of Absorption of 35S- labelled thiamine 
The radioactive material was diluted with non -radioactive thiamine 
so that each test dose contained 1.0mg and 10,0c of radioactivity dissolved 
in 20m1 of water. A quantity of the solution from which the test dose was 
prepared was used as a standard. The test dose was given orally to subjects 
after an overnight fast, and in some experiments a parenteral injection of 
non -radioactive thiamine was given immediately before the oral dose. The 
standard test referred to later includes both a 1.0mg oral dose of radio- 
active thiamine and a parenteral injection of 200mg non -radioactive thiamine 
given at the same time as the oral dose. Absorption was assessed by measuring 
the urinary radioactivity during the following 24 hours. The urine collections 
were removed after the intervals 0 -5 hours, 5 -12 hours, 12 -2L- hours, the 
volume measured and a sample stored at -20 °C until the radioactivity was 
measured. The urine samples were counted in an Isotope Developments Ltd, 
Reading, Berkshire, liquid scintillation counter type 6012, using 0.8gm per 
cent of 2 -5 diphenyloxazole and 0.005gm per cent of 1,4 - - bis (25phenyloxazoM 
benzene dissolved in toluene as the liquid scintillator. The samples were 
prepared by adding 1.0m1 urine to 3m1 hyamine chloride, 1.5M solution in 
methanol, and adding 10m1 liquid scintillator. l0,pc of the test dose was 
added as an internal standard to each sample. 
Identity of the radioactivity present in intestinal contents and urine 
after oral administration of 35S- labelled thiamine; Urine was colled-bed 
in a brown bottle surrounded by a freezing mixture of ice and solid carbon 
diòxide (Drikold, ICI Ltd), during the periods 0 -12 hours, 14 -3 hours, 
3 -12 hours. Following voiding, the urine was either analysed immediately 
or stored at -20 °C. A modification of the phenol extraction procedures of 
Iacono & Johnson (1957) was used to extract the radio -metabolites from the 
urine. Over 90) of the radioactivity was removed by this method. 
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Descending chromatography was performed on Whatman No. 1 paper using 
N- propanol- water -IM acetate buffer p115(70:20 :10), the upper phase of 
N- butanol /acetate acid/water (40:10:50), and the upper phase of sec- 
butanol/water as solvents. The papers were scanned in a BTL Radioactive 
Chromatogram Scanner and radioautographs were prepared with Gavert 
no- screen X -ray film; the film was exposed to the chromatogram for up 
to three months, depending on the amount of radioactivity. 
Identification of Thiamine Compounds on Paper Chromatograms 
A. Thiochrome Test. After drying the chromatograms at room temperature 
thiamine and its esters present on the paper were converted to the corres- 
ponding thiochromes by the method of Siliprandi & Siliprandi (1954.); this 
test will detect 1.0Ng thiamine. 
B. Use of Micro -organisms. Some chromatograms were not sprayed but were 
scanned and the radioactivity eluted with 3m1 distilled water. The ability 
of the eluate to support growth of 0.danica which requires intact thiamine 
(Heinrich, 1955; Baker, Frank, Fennelly & Leevy, 1964), was compared with 
a control consisting of an equivalent area cut from the same chromatogram. 
The method of Baker et al (1964) was used for thiamine assay. Following 
incubation, the material was centrifuged at 3,000 revolutions per minute for 
30 minutes and subsequently washed by centrifuging after resuspension in two 
aliquots of 20m1 sterile distilled water. The radioactivity could not be 
washed from the organisms. The organisms were finally suspended in gel - 
scintillator and the radioactivity present counted by well -scintillation 
counting. 
C. Separation of Radioactive Compounds. To confirm that complete separation 
had been achieved, two chromatograms were run in each of the three solvent 
systems and the radioactivity corresponding to thiamine eluted as above. 
Each of the eluates was then re -run in a different chromatographic solvent 
system and produced a single spot at the same Rf as thiamine. The radio - 
autographs also showed a single discrete spot. 
Demonstration of Thiamine and its Metabolites in the Urine. Four patients 
were given 300mg of non -radioactive thiamine hydrochloride intravenously 
4.8 hours before the experiment. On the day of the experiment, they received 
the standard test of 1.0mg oral radioactive thiamine hydrochloride and 
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200mg non -radioactive thiamine intravenously. In three subjects, over 903.'6 
of the radioactivity excreted during the 0 -12 hour period had the sane Rf 
as thiamine in all three solvent systems and gave a positive thiochrome test. 
The eluted radioactive substances supported the growth of 0.danica and the 
radioactivity could not be washed from the cells. In the fourth subject, 
during the period 12 -3 hours after the dose 9/ of the radioactivity was due 
to thiamine but this fell to 6 ' in the 3 -12 hour period. No attempt was 
made to identify the other radioactive compounds. 
Extraction of Radio- metabolites from Small Intestinal Juice. Two normal 
subjects were intubated using a 1.5mm bore polyvinyl tube weighted at one 
end. The duodenal- jejunal junction is approximately 90cm and the ileo- 
caecal valve 350cm from the nose in adults (Blankenhorn, Hirsch & Ahrens, 1955). 
Sampling in one subject . was from points 105cm and 195cm from the nose on two 
successive days, i.e. from the jejunum and from the oroximal ileum; in the 
other, sampling was only from the proximal ileum. The fasting subjects were 
fed a test meal consisting of "Humanised Trufood" (Trufood Ltd, The Creamaries, 
Wrenbury, Cheshire) and Sic of 35S- thiamine with sufficient non -radioactive 
thiamine to give a final thiamine content of 1.0mg. The small intestinal 
juice was obtained by continuous sampling into a flask surrounded by a freezing 
mixture. The volume of intestinal juice decreased considerably after the third 
hour. Consequently, the observations relate to the 0 -3 hour period. The pH 
of the intestinal juice was measured with a glass electrode and never rose above 
pH 6.1, i.e. it was always within the range at which thiamine is stable. At 
the end of the experiment, gastrografin was introduced into the tube to check 
the position of the sampling point. 
Twenty ml of small intestinal juice were dialysed against three 100m1 
portions of distilled water left for 24 hours at 4 °C. The dialysatesmere 
freeze -dried and then dissolved in 30m1 absolute ethanol. The solution 
was concentrated in vacuo at 35 °C to about 4n1 and a sample chromatographed. 
It was found that over 90j& of the radioactivity was identical, chromato- 
graphically, with thiamine. 
Subjects Studied 
Controls were sixty five convalescent, ambulant hospital patients free from 
gastro -intestinal, endocrine, collagen and malignant diseases. They had 
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normal hepatic and renal function and were not receiving drug therapy. 
They showed no signs of nutritional deficiency. 
Patients with primary malabsorptive disease included 10 cases who had not 
been treated with a gluten free diet. The diagnosis was established by 
jejunal biopsy and the results of the following absorption tests - folic 
acid absorption ( Girdwood, 1953; Girdwood & Delamore, 1961), vitamin B12 
absorption (Schilling, 1953) xylose absorption (Fourman, 1948) and faecal 
fat excretion (Kamer, Bokkel, Huinink & Weyers, 1949) . A sternal marrow 
was performed and serum folate, formininoglutamic acid (r'1GLU), and vitamin B12 
levels were measured. All patients had a barium meal and follow- through 
examinations. There were also 13 patients who had been treated with a gluten 
free diet for periods varying from 3 months to 5 years. 
The other patients included 10 who had had gastric surgery and three 
patients with pernicious anaemia who had confirmed acid -fast achlorhydria 
in response to a maximum histamine test meal and were untreated at the time 
of investigation. Three patients had Crohn' s disease and one who had had a 
sub -total proximal gastrectomy with an end -to -side oesophago -gastric anasta- 
mosis for an anaplastic carcinoma of the stomach 17 years previously, but there 
was no postmortem evidence of a recurrence when she died from a myocardial 
infarction some months after completion of the studies. Two of the patients 
with Crohn's disease had had a resection of the terminal ileum and a right 
hemicolectomy. 
RESULTS 
Investigation of Test Conditions. The excretion of radioactivity when ten 
control subjects were only given 1.0 mg of radioactive thiamine orally was 
6.1%(SEM± 0.64) but if the oral dose was preceded by giving 300 mg of non- 
radioactive thiamine intravenously 48 hours before the excretion of radioactive 
thiamine rose to 15.3`L(ß± 2.63). This difference is highly significant. 
(t= tß.26, pc0.01). 
The Standard Test. The effect of varying the size of an intravenous dose 
of non -radioactive thiamine given at the same time as the oral dose of radio- 
active material was studied and the optimum amount for this intravenous 
flushing dose was found to be 200mg. This dose ensured maximal excretion and 
was thereafter used in the standard test of thiamine absorption (Table 1). 
Giving thiamine to control subjects two days before they received the standard 
TABLE 1 
TWENTY FOUR HOUR URINARY EXCRETION OF RADIOACTIVE 
THI LINE BY NORMAL SUBJECTS 
The effect of injecting varying amount := of non -radioactive 
thiamine at the time of administering 1.0mg radioactive 
thiamine by mouth on the excretion of radioactive thiamine 
in the urine. 
Intravenous dose of non - Urinary excretion of radioactivity 
radioactive thiamine jc' oral close* 
mg Before loading After loading** 
0 6.1 ± 0.64 (lo) 15.3 ± 2 .64 (6) 
25 35.0 ± 2 .95 (5) 
50 39.5 ± 3 .18 (7) 
100 51.7 t 5.04 (9) 
200 48.2 t 4.54 (lo) 54.1 ± 5 .66 (lo) 
300 50.2 ± 3 .66 (8) 
* The results are expressed as the mean t í (n) Urine was 
collected for 21_ hours. 
** Subjects given 300mg thiamine i.v. 4B hours before test, and 



















Fig 1. Cumulative urinary excretion of radioactivity 
after 1.0mg 35S- thiamine orally and 200mg non- 
radioactive thiamine intravenously in a control 
subject and in a patient with primary malabsorptive 
disease. 
TABLE 2 
EbIÉECT OF VARYING THE TIME OF TIE INITIAL, FLUSHING 
DOSE AND GIVING ADDITIONAL INTRAVENOUS FLUSHING DOSES 
Subjects were given two tests: First* and Second ** and 
received 300mg non -radioactive thiamine intravenously 
4.8 hours before each test. 
Subject Test 35S- thiamine urinary excretion 
1 First 49.0 
Second 53.0 
2 First 49.0 
Second 49.0 
3 First 41.7 
Second 41.2 
4 First 75.0 
Second 80.0 
5 First 58.5 
Second 58.0 
6 First 59.9 
Second 59.0 
* First test = 1.0mg radioactive thiamine orally and 
200mg non -radioactive thiamine flushing 
dose intravenously at the same time. 
** Second test = Subjects 1 -3 same as first test with 
additional 100mg flushing doses at 2,6 
and 12 hours after oral dose. 
4 same as first test with 
additional 200mg at 4 hours 
5 received 200mg i.m. only 
at time of oral dose 
6 no flushing dose at time 





The radioactivity in serum and urine after 
administration of radioactive thiamine given 






Fig. 2b The radioactivity in serum and urine after 
administration of radioactive thiamine intra- 
muscularly on a different occasion to the same 
control :subject as in Fig. 2a. 200mg non -radioactive 








test did not alter the mean urinary excretion of radioactivity. (t = 0.814; 
0.2(p<0.5). 
Figure 1 shows the cumulative excretion of radioactivity after 200mg 
flushing dose in a control subject who previously received 300mg thiamine 
intravenously 48 hours before. Excretion was maximal between 1 -2 hours 
during which time 41% of the dose was excreted. By 12 hours, excretion 
was almost complete, ,V0 being added in 12 -24 hours, and further small 
amounts thereafter (3.4 in 24 -48 hours and 4.12, in the 48 -96 hour period 
after which excreted radioactivity was too small to be measured accurately). 
The decline in the rate of excretion of urinary radioactivity two hours 
after the standard test, may not have been due to a decrease in the absorption 
of oral thiamine but may have followed a fall in the blood level of the 
flushing dose. due to the rapid excretion. Consequently, radioactive thiamine 
(5.0 )c) was incorporated in a 200mg intravenous injection on non -radioactive 
thiamine to investigate the duration of the flushing dose. This showed that 
4.5% (9.0mg) ofthe intravenous dose was still being excreted during the 
4 -5 hour period. Similarly, varying the time of the flushing dose or main- 
taining a high blood level of non -radioactive thiamine during the first 16 hours 
by repeated injection had a negligible effect on the total urinary recovery. 
(Table 2). When the standard test alone was repeated in four subjects, the 
following results were obtained: 46.0:, 38.4ìt,; 49.0¡x, 54.E ; 58.LN, 54.7; 
60.0% and 62.7. 
Eighty eight per cent of the intravenous dose was recovered during the 
first 24 hours and 90(A after the radioactive thiamine was given intra- 
muscularly to the same subject (Figs 2a and 2b). Another subject excreted 
93'% of an intravenous dose in 24 hours. Consequently, it seems that prac- 
tically all of the oral dose absorbed, once it reaches the blood stream, will 
probably be excreted during the first 24 hours, under the conditions of the 
standard test. 
STUDIES ON PATIENTS 
Primary Malabsorptive Disease. The excretion of eight patients with primary 
malabsorptive disease given 300mg intravenously 48 hours before the standard 
test was 26.7(SEM ± 5.11) which was significantly less than the control group 
(t = 3.504; p40.01). When the 300mg "loading" dose was omitted there was no 
decrease in the recovery of urinary radioactivity 28.1jo(SEa1 ± 4.75). The 
difference between these patients and the controls was not due to a decreased 
TABLE 3 
EFFECT OF ADDITIONAL FLUSHING DOSES IN A PATIENT 
WITH UNTREATED PRIMLY laLAI3SORPTIVE DISEASE 
The patient was given 300mg thiamine intravenously 
48 hours before each test. 
Time 
hr 
Urinary radioactivity Time of additional 
after Standard Test 100mg i.v. flushing 
doses of thiamine, 










4-6 4.8 6.1 
6 hr 
6 -12 6.4 10.9 
12 hr 
12 -24 6.3 5.0 
25.2 29.3 
TABLE ¿i 
TECAIVNE ABSORPTION IN PATIENTS WITH PRIMARY MALLABSORPTIVE DISEASE 
Standard test repeated in the same subject after giving 3O0mg 
thiamine intravenously 48 hours before the second test. 





28.1 t 4.75 
36.9±4.33 
26.7 ± 5.11 
40.8±3.84 
The results are expressed as the mean t SEM (n) 
Loading was achieved as before.: (see Table 1 
Primary Castro - Crohn's Pernicious 
































Fig 3. Thiamine absorption in various clinical states 
7. 
ability to excrete thiamine as a patient was able to excrete an intravenous 
dose normally. The cumulative excretion of radioactivity in a "loaded" 
untreated patient showed delay in excretion and marked reduction in the total 
excreted 9.4. although maximal excretion occurred within the first 6 hours. 
Additional flushing doses given to three malabsorptive patients during the 
0 -24 hour period and to two others during the 24-48 hour period did not 
alter the pattern of excretion or significantly increase the total radio- 
activity excreted; the details of one patient are shown in Table 3. 
In thirteen patients who had been treated with a gluten free diet and 
replacement therapy, previous loading again had no effect on the excretion 
of radioactivity (Table 4). The previously "loaded ", treated patients did 
not differ from the control group (t = 2.012; 0.5 <p<0.1) but differed sig- 
nificantly from the untreated patients (t = 2.231; 0.02<pc0.05). 
Miscellaneous Conditions. the results of eight patients with gastroentero- 
stomies are shown in Figure 3 and there is no evidence of abnormal absorption 
(t = 0.395; p:0.5). 
One patient with a partial gastrectomy excreted 71.6% of the oral dose 
while another excreted only 3.8%; this second patient had an abnormal villous 
pattern which may have been associated with altered gastric function. Be 
excreted 89% in the first 21+ hours when the same dose was given intravenously. 
A patient who had had a sub -total gastrectomy 17 years previously excreted 65.5% 
Three patients with Crohn's disease involving the terminal ileum, who 
had evidence of malabsorption of Vitamin B12 and a reduced serum vitamin B12 
level, gave normal results. Four patients with untreated pernicious anaemia 
also showed normal results. 
DISCUSSION 
These investigations indicate that radioactive thiamine can be used to 
study the absorption of this vitamin in man. Analysis of small intestinal 
juice and extraction of the radioactivity present in the urine, shows that 
during the period when maximal absorption is taking place, little breakdown 
of thiamine occurs in the small intestine and that most of the radioactivity 
obtained in the urine is thiamine which was unchanged prior to absorption. 
When a relatively large injection of non -radioactive thiamine is given 
intravenously, the percentage excretion of radioactivity rises from about 
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6.0jö to over 50.0 %. Since the non -radioactive parenteral thiamine promotes 
the urinary excretion of the labelled vitamin, it would seem that the radio- 
active thiamine behaves similarly to the non -radioactive thiamine during its 
passage through the body. Increasing the flushing dose to 300mg thiamine 
does not produce any further increase in the percentage urinary excretion 
of radioactive thiamine (Table 1; p <0.5) and it would therefore::seem unlikely 
that the flushing dose is altering the normal physiological activity of the 
intestine. 
If an absorption test is to be sensitive to physiological amounts of 
the test substance, the size of the test dose must be large enough to show 
that the subject is capable of absorbing his minimum daily requirement during 
the 24 hours but must not exceed the reserve capacity of the intestine in the 
control subject. The minimum daily requirement of thiamine for the adult 
human has been estimated at between 0.23mg/1000cal and 0.66mg/1000cal 
(Williams, Mason, Smith & Wilder, 1942; Oldham, Johnston, Kleiger & Hedderich- 
Arismendi, 1944; Daum, Tuttle & Wilson, 19L.9; Dick, Chen, Bert & Smith, 1958 
and Ziporin, Nunes, Powell, Waring & Sauberlich, 1965). The work of Morrison 
& Campbell, (1960); Friedemann, Kmieciak, Keegan & Sheft (19L8) and Schultz, 
Light & Frey (1938) suggests that little further absorption occurs when the 
dose of thiamine exceeds 4 -5mg. Therefore, 1.0mg was chosen as a reasonable 
oral dose. 
Although one control patient excreted 90.7ít, of the oral dose within 
the first 24 hours, the mean excretion for the group was only 54.1%(SEM± 5.66) 
and prolonging the urine collection for nine days in one subject added only a 
further 7.5F /c. The total thiamine content of the human bddy has been estimated 
to be 30mg (Takeda, 1947). Approximately 0.05mg of radioactive thiamine is 
contained in the oral dose. An attempt was made to reduce any exchange with 
the body stores by previous loading of the patient and by the provision of 
additional flushing doses each of 200mg of non -radioactive thiamine to dilute 
the absorbed radioactive thiamine. However, giving additional flushing doses 
or variation in time or route of administration of the flushing dose, did not 
significantly increase the total 24 hour excretion of activity nor alter the 
pattern of excretion. Also Yano (1958) recovered approximately 0.5mg of a 
2.0mg oral dose of thiamine from the stool. Consequently, it would seem 
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that most of the oral dose absorbed is excreted during the first 24 hours, 
under the conditions of the test. Haugen (1961) showed that excessive amounts 
of thiamine are rapidly excreted by the kidney and in the present investigations 
there was no evidence that at any time the kidneys were unable to excrete the 
load presented to them. 
In control subjects the major period of absorption was in the first two 
hours after the oral dose (Fig. 1). The work of Middleton & Grice (1964) in 
the rat indicates that the site of maximum absorption for thiamine is in the 
duodenum and upper small intestine, and this agrees with the findings of Polin, 
Loukides, Wynosky & Porter (1964) in the chick. Three patients with Crohn's 
disease involving the lower small intestine and showing impaired absorption of 
vitmnin B12 excreted normal amounts of radioactivity after the standard test 
for thiamine, suggesting that absorption of vitamin B1 in the human is mainly 
in the upper small intestine. 
Wang & Harris (1939) and Brummer & Markkanen (1960) measured the doily 
urinary excretion of dietary thiamine in achlorhydric subjects found evidence 
of reduced excretion indicating depletion which might have been secondary to 
reduced absorption. During the present investigation, four patients with 
pernicious anaemia and three with histamine fast achlorhydria following gastric 
surgery, were all found to excrete normal amounts of radioactivity. If absor- 
ption is grossly impaired, malabsorption may become apparent when the test dose 
is small. A larger dose, however, may result in a greater difference between 
normals and patients or may demonstrate impairment which was not obvious with 
the smaller dose as occurs with xylose absorption. Consequently, the results 
in achlorhydria are not necessarily incompatible with the observations of Wang 
& Harris (1939) and Brummer & Markkanen (1960) although there may be other factors 
producing depletion in their patients. 
The paired t -test showed no significant difference between malabsorptive 
patients who had been previously loaded and those who had not, either before, 
or after treatment. It was also shown that the mean of the untreated malabsor- 
ptive patients, with previous "loading" was significantly less than the treated 
patients. However, the mean of the treated malabsorptive patients, who were not 
given 300mg 48 hours before treatment, was low. Consequently, further statistical 
tests were applied. Seven of the eight differences in the untreated patients 
10, 
were positive but the result of the Wilcoxon's sign test (Spiegel, 1956) confir- 
med the t -test findings. Similarly, in control subjects, previous "loading" 
did not significantly alter the result. Consequently, the average of the 
result before and after "loading" was taken in each malabsorptive patient 
and the resulting two groups compared with the control group considered as 
twenty independent observations. A one-way analysis of variance on these 
three groups was found to be highly significant confirming the difference 
between the untreated and control groups. Pi t 5.21; d.f.(2,3817 = 0.99. 
The one -tailed t -test applied to the average of the treated and untreated 
malabsorptive patients, gave t = 1.8 with 19 d.f. and this was significant 
at the five per cent level. There was no correlation between the ability 
of the malabsorptive patients to absorb thiamine and other intestinal 
absorption tests or with the severity of the changes shown by jejunal 
biopsy. The results in.these patients illustrate again the variation in 
the ability of individual patients to absorb different substances during 
the acute phase of the disease. 
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